Grünenthal returns to debt markets for revolver after HY bond debut

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Syndicated Loans
Leveraged Loans

Grünenthal returns to debt markets for revolver after HY bond debut

Mike Turner
May 17, 2021 12:30 pm
pills adobe stock 575x375 pharmaceuticals
Heap of medical pills in white, blue and other colors. Pills in plastic package. Panoramic banner for design. | OKSANA KAZYKINA/okskaz - stock.adobe.com

Grünenthal, the German opioid maker, has signed a €400m revolving credit facility, less than a month after making its postponed debut in the high yield bond market.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • ✔ 4,000 annual insights
  • ✔ 700+ notes and long-form analyses
  • ✔ 4 capital markets databases
  • ✔ Daily newsletters across markets and asset classes
  • ✔ 2 weekly podcasts

Topics

Responsible InvestmentDeutsche BankSyndicated LoansINGBBVARBC Capital MarketsBNP ParibasLoans and High YieldLeveraged LoansLevFinLevFin Leveraged LoansUniCreditSRIGoldman Sachs
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article